Register
Login:
Share:
Email Facebook Twitter


Exclusive: Hayden Locke, CEO Emmerson plc, a low cost high margin potash investment
Richard Slape, Oil consultant - Avoiding Losers and Picking Winners, his personal strategy




Share Price Information for Physiomics (PYC)


Share Price: 3.15Bid: 3.00Ask: 3.30Change: 0.00 (0.00%)No Movement on Physiomics
Spread: 0.30Spread as %: 10.00%Open: 3.20High: 0.00Low: 0.00Yesterday’s Close: 3.15

Physiomics Plc Ord 0.4P

Physiomics is listed in the FTSE AIM All-Share
Physiomics is part of the Health Care and Related Services sector






Share Price SpacerPrice
3.15
Share Price SpacerBid
3.00
Share Price SpacerAsk
3.30
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
0
Share Price SpacerOpen
3.20
Share Price SpacerHigh
0.00
Share Price SpacerLow
0.00
Share Price SpacerClose
3.15
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 71.91m £2.27m 30,000

52 Week High 8.95 52 Week High Date 24-APR-2018
52 Week Low 3.05 52 Week Low Date 15-MAR-2019

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
0 0 0 -10.161 -0.31 0.00 0.00


London South East Users info for Physiomics




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

22-Mar-19
10:02:31
3.27
14,908
Buy* 
3.00
3.30
487.49
Trade Type:
Ordinary

22-Mar-19
09:45:06
3.065
5,000
Sell* 
3.00
3.30
153.25
Trade Type:
Ordinary

22-Mar-19
08:17:45
3.065
2,500
Sell* 
3.00
3.30
76.63
Trade Type:
Ordinary




View more Physiomics trades >>

Directors Deals for Physiomics (PYC)
Trade DateActionNotifierPriceCurrencyAmountHolding
22-Dec-16Notification of Holding
Trade Notifier Information for Physiomics
Christophe Chassagnole held the position of COO at Physiomics at the time of this trade.
 Christophe Chassagnole
00151897
22-Dec-16Buy
Trade Notifier Information for Physiomics
James Simon Millen held the position of CEO at Physiomics at the time of this trade.
 James Simon Millen
2.5GBX200,000200000
18-May-12Buy
Trade Notifier Information for Physiomics
Mark Chadwick held the position of CEO at Physiomics at the time of this trade.
 Mark Chadwick
0.12GBX3,970,1513970151
View more Physiomics directors dealings >>


Gunthorpe
Posts: 259
Opinion:No Opinion
Price:3.20
RE: Only 3.6m shares required
Thu 10:02
I have 230,000. Not massive, but cost me well over 10k. Feel the potential here has either been deliberately over inflated or the sales team need replacing as they cant convert this potential in to orders. I will co ordinate if enough pledge their shares to calling an EGM. This is actually turning out worse than some other BIo lifestyle companies who have ( currently) a far worse reputation. Line in the sand time.
Aberystwyth
Posts: 913
Opinion:No Opinion
Price:3.30
RNS FELT LIKE DESPERATION
Thu 08:47
The muppets running this company presumably thought that this RNS WOULD up the SP as they have no other news to stop the rot ... turnover about the same as the small shop on the pier .. no new business being generated so desperation mode kicking in ... only newsflow seems to be when they need something like a placing .. and unfortunately the products cannot be developed and sold wholesale across the world in large quantities as each solution is targeted to a specific companies requirement and the sales team sell the work at just a tad above the salary cost for the work .. so profit minimised ... hence I cannot see much upside to this companies business strategy
Ralphiebabe
Posts: 1,132
Opinion:No Opinion
Price:3.40
AACR
Thu 06:08
For the presentation of:-
677 / 10 - A precision dosing application for prostate cancer chemotherapy.
They’re there to get some serious backer for this project, or it’s one big jolly as just about all staff attending!
Presenter/Authors,
Claire Villettte, Hitesh Mistry, Fernando G. Ortega, David Orrell, Frances A. Brightman, Jim Millen, Christophe Chassagnole. Physiomics plc, Oxford, United Kingdom.
riddler
Posts: 83,072
Premium Chat Member
Opinion:No Opinion
Price:3.40
Total income up 162%
Wed 15:31
otal income for the period increased 162% to £372k compared with £142k in the comparable prior period. Total income for the period comprised the second half of the 2018 Merck projects, revenues from new clients announced during the calendar year and grant income from Innovate UK.
riddler
Posts: 83,072
Premium Chat Member
Opinion:No Opinion
Price:3.40
Gunthoroe
Wed 15:22
If you arent happy sell
View more share chat for Physiomics (PYC) >>




Physiomics Plc Ord 0.4P home pageWebsite: Physiomics Plc Ord 0.4P
Website Description: Home



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk











Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.